Option Care Health Inc (OPCH)
Official siteHEALTHCARE • MEDICAL CARE FACILITIES • NASDAQ
Market Cap: $4.74B
Last updated: Nov 17, 2026 at 11:06 AM ET
Option Care Health Inc (OPCH) Earnings: Report Dates and Results
Option Care Health (OPCH) is expected to report earnings on Jan 11, 2027. In the quarter ended Sep 30, 2026, Option Care Health reported EPS of $0.44, in line with the $0.44 estimate. It beat the EPS estimate in 6 of the last 8 quarters.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
OPCH has an expected report date of Jan 11, 2027. Analysts' consensus for the quarter ending Dec 31, 2026 is 21.7% above the $0.46 reported for the quarter ended Dec 31, 2025.
OPCH Earnings Call
The latest OPCH earnings call transcript on file is labeled 2026Q2.
Read the 2026Q2 transcriptEarnings History
Of the 40 quarters below that had an estimate, OPCH beat 24, missed 12 and matched 4. Revenue for the quarter ended Sep 30, 2026 was $1.49B, up 3.5% from $1.44B a year earlier.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported | Revenue |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | $0.44 | $0.44 | N/A | 0.00% | In line | -2.2% | 11 | 5 up, 3 down | Nov 4, 2026 | $1.49B |
| Jun 30, 2026 | $0.41 | $0.37 | N/A | +10.81% | Beat | 0.0% | 11 | 0 up, 1 down | Jul 29, 2026 | $1.44B |
| Mar 31, 2026 | $0.40 | $0.37 | $0.35 - $0.39 | +8.11% | Beat | 0.0% | 10 | 0 up, 3 down | Apr 30, 2026 | $1.35B |
| Dec 31, 2025 | $0.46 | $0.47 | $0.45 - $0.50 | -1.20% | Miss | +24.5% | 10 | 3 up, 0 down | Feb 24, 2026 | $1.47B |
| Sep 30, 2025 | $0.45 | $0.43 | $0.41 - $0.44 | +4.65% | Beat | +36.4% | 7 | 3 up, 2 down | Oct 30, 2025 | $1.44B |
| Jun 30, 2025 | $0.41 | $0.40 | $0.38 - $0.41 | +2.50% | Beat | +32.3% | 6 | 1 up, 3 down | Jul 30, 2025 | $1.42B |
| Mar 31, 2025 | $0.40 | $0.34 | $0.27 - $0.36 | +17.65% | Beat | +48.1% | 7 | 3 up, 0 down | Apr 29, 2025 | $1.33B |
| Dec 31, 2024 | $0.37 | $0.36 | $0.32 - $0.44 | +2.01% | Beat | +15.5% | 5 | 1 up, 0 down | Feb 26, 2025 | $1.35B |
| Sep 30, 2024 | $0.33 | $0.32 | $0.28 - $0.36 | +3.13% | Beat | 0.0% | 9 | 0 up, 0 down | Oct 30, 2024 | $1.28B |
| Jun 30, 2024 | $0.31 | $0.28 | $0.25 - $0.31 | +10.71% | Beat | +3.3% | 9 | 0 up, 0 down | Jul 31, 2024 | $1.23B |
| Mar 31, 2024 | $0.27 | $0.22 | $0.19 - $0.25 | +22.73% | Beat | +28.6% | 8 | 0 up, 1 down | Apr 23, 2024 | $1.15B |
| Dec 31, 2023 | $0.32 | $0.29 | $0.26 - $0.31 | +10.34% | Beat | +33.3% | 8 | 0 up, 0 down | Feb 22, 2024 | $1.12B |
| Sep 30, 2023 | $0.33 | $0.29 | $0.24 - $0.31 | +13.79% | Beat | +57.1% | 8 | 0 up, 0 down | Oct 25, 2023 | $1.09B |
| Jun 30, 2023 | $0.30 | $0.24 | $0.19 - $0.27 | +25.00% | Beat | +50.0% | 8 | 0 up, 0 down | Jul 27, 2023 | $1.07B |
| Mar 31, 2023 | $0.21 | $0.18 | $0.15 - $0.20 | +16.67% | Beat | +16.7% | 8 | 0 up, 0 down | May 3, 2023 | $1.02B |
| Dec 31, 2022 | $0.24 | $0.24 | $0.19 - $0.24 | 0.00% | In line | -41.5% | 6 | 0 up, 0 down | Feb 23, 2023 | $1.03B |
| Sep 30, 2022 | $0.21 | $0.24 | N/A | -12.50% | Miss | -4.5% | 6 | 0 up, 0 down | Oct 27, 2022 | $1.02B |
| Jun 30, 2022 | $0.20 | $0.22 | $0.17 - $0.26 | -9.09% | Miss | +5.3% | 6 | 0 up, 0 down | Jul 27, 2022 | $980.82M |
| Mar 31, 2022 | $0.18 | $0.12 | $0.11 - $0.16 | +50.00% | Beat | +100.0% | 6 | 0 up, 0 down | Apr 28, 2022 | $915.78M |
| Dec 31, 2021 | $0.41 | $0.24 | $0.20 - $0.29 | +70.83% | Beat | +310.0% | 6 | 0 up, 0 down | Feb 23, 2022 | $927.19M |
| Sep 30, 2021 | $0.22 | $0.22 | $0.14 - $0.22 | 0.00% | In line | +266.7% | 7 | 1 up, 0 down | Nov 4, 2021 | $891.94M |
| Jun 30, 2021 | $0.19 | $0.10 | $0.06 - $0.11 | +90.00% | Beat | +1800.0% | 7 | N/A | Aug 3, 2021 | $860.27M |
| Mar 31, 2021 | $0.09 | $0.04 | -$0.01 - $0.04 | +125.00% | Beat | N/A | 6 | N/A | May 6, 2021 | $759.24M |
| Dec 31, 2020 | $0.10 | $0.07 | $0.03 - $0.09 | +42.86% | Beat | N/A | 6 | N/A | Mar 11, 2021 | $804.71M |
| Sep 30, 2020 | $0.06 | -$0.01 | -$0.08 - -$0.01 | +700.00% | Beat | N/A | 5 | N/A | Nov 3, 2020 | $781.61M |
| Jun 30, 2020 | $0.01 | -$0.14 | -$0.18 - -$0.04 | +107.14% | Beat | N/A | 5 | N/A | Aug 4, 2020 | $740.85M |
| Mar 31, 2020 | -$0.06 | -$0.07 | -$0.12 - -$0.04 | +14.29% | Beat | N/A | 4 | N/A | May 7, 2020 | $705.44M |
| Dec 31, 2019 | -$0.09 | -$0.06 | N/A | -50.00% | Miss | N/A | N/A | N/A | Mar 5, 2020 | $720.78M |
| Sep 30, 2019 | -$0.07 | -$0.08 | N/A | +12.50% | Beat | N/A | N/A | N/A | Nov 6, 2019 | $615.88M |
| Jun 30, 2019 | -$0.52 | -$0.35 | N/A | -48.57% | Miss | N/A | N/A | N/A | Jul 30, 2019 | $497.27M |
| Mar 31, 2019 | -$0.40 | -$0.49 | N/A | +18.37% | Beat | N/A | N/A | N/A | May 2, 2019 | $476.49M |
| Dec 31, 2018 | -$0.56 | -$0.56 | N/A | 0.00% | In line | N/A | N/A | N/A | Mar 15, 2019 | $1.10B |
| Sep 30, 2018 | -$0.36 | -$0.30 | N/A | -20.00% | Miss | N/A | N/A | N/A | Nov 6, 2018 | $493.93M |
| Jun 30, 2018 | -$0.56 | -$0.46 | N/A | -21.74% | Miss | N/A | N/A | N/A | Aug 7, 2018 | $175.79M |
| Mar 31, 2018 | -$0.48 | -$0.53 | N/A | +9.43% | Beat | N/A | N/A | N/A | May 10, 2018 | $168.58M |
| Dec 31, 2017 | -$0.08 | -$0.08 | N/A | -3.23% | Miss | N/A | N/A | N/A | Mar 8, 2018 | $1.19B |
| Sep 30, 2017 | -$0.48 | -$0.38 | N/A | -26.32% | Miss | N/A | N/A | N/A | Nov 2, 2017 | $198.69M |
| Jun 30, 2017 | -$0.60 | -$0.48 | N/A | -25.00% | Miss | N/A | N/A | N/A | Aug 8, 2017 | $218.11M |
| Mar 31, 2017 | -$0.72 | -$0.58 | N/A | -24.14% | Miss | N/A | N/A | N/A | May 4, 2017 | $217.81M |
| Dec 31, 2016 | -$0.92 | -$0.34 | N/A | -170.59% | Miss | N/A | N/A | N/A | Mar 3, 2017 | $240.12M |
Estimates made before a stock split are shown on the same share basis as the reported EPS.
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was $1.72, up 34.4% from the year before. It was -$2.20 for the year ended Dec 31, 2016, the oldest of the 10 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | $1.72 | +34.4% |
| Dec 31, 2024 | $1.28 | +10.3% |
| Dec 31, 2023 | $1.16 | +39.8% |
| Dec 31, 2022 | $0.83 | -8.8% |
| Dec 31, 2021 | $0.91 | +727.3% |
| Dec 31, 2020 | $0.11 | N/A |
| Dec 31, 2019 | -$1.08 | N/A |
| Dec 31, 2018 | -$1.96 | N/A |
| Dec 31, 2017 | -$1.88 | N/A |
| Dec 31, 2016 | -$2.20 | N/A |
Earnings Calls
The 8 most recent earnings calls are listed below; the latest, 2026Q2 for the period ended Jun 30, 2026, runs about 5,700 words across 14 speakers.
| Call | Period ending | Words | Speakers | Transcript |
|---|---|---|---|---|
| 2026Q2 | Jun 30, 2026 | 5,739 | 14 | |
| 2026Q1 | Mar 31, 2026 | 8,083 | 15 | |
| 2025Q4 | Dec 31, 2025 | 8,292 | 14 | |
| 2025Q3 | Sep 30, 2025 | 7,093 | 12 | |
| 2025Q2 | Jun 30, 2025 | 5,948 | 11 | |
| 2025Q1 | Mar 31, 2025 | 7,948 | 12 | |
| 2024Q3 | Sep 30, 2024 | 7,601 | 12 | |
| 2024Q2 | Jun 30, 2024 | 8,148 | 11 |
2026Q2 Earnings Call
Opening remarks
Bob Okunski Vice President, Investor Relations Good morning, and welcome to Option Care Health's Second Quarter 2026 Earnings Conference Call. With me today are John Charles Rademacher, President and Chief Executive Officer and Meenal Anil Sethna, Executive Vice President and Chief Financial Officer. Before we begin, a reminder that today's discussion will include certain forward-looking statements that reflect our current assumptions and these forward-looking statements are subject to various risks and uncertainties that could cause actual results to differ materially from our expectations. We assume no obligation to update any forward-looking statement except as required by law. We will also use non-GAAP financial measures when talking about the company's performance and financial condition. For more information on the specific risks and uncertainties as well as our non-GAAP measures, we encourage you to review the information in today's press release which is posted on the Investor Relations portion of our website as well as in our Form 10-Ks and 10-Qs filed with the SEC. Finally, for the question-and-answer portion of today's call, we ask that you limit questions to one question and one follow-up per participant. With that, I will turn the call over to John. John?
John Charles Rademacher President and Chief Executive Officer Thanks, Bob. Good morning, everyone, and thank you for joining us. We are pleased to share updates on our second quarter 2026 today. Before I do this, I want to take a moment to say thank you to the Option Care Health team for their unwavering commitment to the patients and communities that we serve every day. I am grateful to our team members whose dedication to clinical excellence, patient outcomes, and service quality continues to differentiate Option Care Health in the marketplace. Their efforts continue to strengthen our foundation and have contributed to the positive momentum we are seeing across the business. As recognition of the great work our team does on a daily basis, we are incredibly proud to be ranked number 15 on TIME's World's Most Impactful Companies of 2026 list, which was presented by TIME and Statista earlier in the second quarter. At a high level, as the nation's largest independent provider of home and alternate site infusion therapy, our strategy is built on a national scale with local responsiveness. Our comprehensive network of home infusion pharmacies and infusion suites, URAC-accredited specialty pharmacy centers of excellence, along with the breadth and depth of our nursing resources, uniquely positions us in the marketplace. We combine consistent high-quality clinical care with local access leveraging our platform of infusion suites and clinics to drive clinical innovation, while meeting patients where they want to be.
Frequently Asked Questions About OPCH
When is Option Care Health's next earnings date?
Option Care Health's next earnings report is expected for Jan 11, 2027.
Did OPCH beat earnings estimates last quarter?
Option Care Health reported EPS of $0.44 for the quarter ended Sep 30, 2026, in line with the $0.44 estimate.
What EPS do analysts expect from OPCH next quarter?
The consensus EPS estimate for Option Care Health for the quarter ending Dec 31, 2026 is $0.56 from 14 analysts, with estimates from $0.52 to $0.59.
How often does OPCH beat earnings estimates?
Option Care Health beat the EPS estimate in 6 of the last 8 quarters, with an average surprise of +5.57%.
OPCH pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors, Government Contracts